---
figid: PMC3372318__EDR2012-789174.003
figtitle: The two major signaling cascades operating in cancer, following overactivation
  of the INSR/IGF-IR signaling pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3372318
filename: EDR2012-789174.003.jpg
figlink: /pmc/articles/PMC3372318/figure/fig3/
number: F3
caption: 'Schematic representation of the two major signaling cascades operating in
  cancer, following overactivation of the INSR/IGF-IR signaling pathways. Binding
  of insulin, IGF-I (and IGF-II) triggers the intrinsic tyrosine kinase receptor domain,
  leading to activation of the PI3K/Akt/mTOR signaling and the MAP/ERK-kinase pathway.
  HR: hybrid receptors; ERK: extracellular regulated kinase; IRS: INSR substrate;
  MEK: mitogen-activated protein kinase kinase; mTOR: mammalian target of rapamycin;
  PI3K: Phosphoinositide-3 kinase; PIP2: phosphatidylinositol [4,5]-bisphosphate;
  PIP3: phosphatidylinositol [3,4, 5]-trisphosphate; PDK1: phosphoinositide-dependent
  kinase 1; Raf: rapidly fibrosarcoma; Ras: rat sarcoma; Rheb: Ras homolog enriched
  in brain; TSC: tuberous sclerosis complex.'
papertitle: 'Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms.'
reftext: Biagio Arcidiacono, et al. Exp Diabetes Res. 2012;2012:789174.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9491928
figid_alias: PMC3372318__F3
figtype: Figure
redirect_from: /figures/PMC3372318__F3
ndex: b8bb047b-def1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3372318__EDR2012-789174.003.html
  '@type': Dataset
  description: 'Schematic representation of the two major signaling cascades operating
    in cancer, following overactivation of the INSR/IGF-IR signaling pathways. Binding
    of insulin, IGF-I (and IGF-II) triggers the intrinsic tyrosine kinase receptor
    domain, leading to activation of the PI3K/Akt/mTOR signaling and the MAP/ERK-kinase
    pathway. HR: hybrid receptors; ERK: extracellular regulated kinase; IRS: INSR
    substrate; MEK: mitogen-activated protein kinase kinase; mTOR: mammalian target
    of rapamycin; PI3K: Phosphoinositide-3 kinase; PIP2: phosphatidylinositol [4,5]-bisphosphate;
    PIP3: phosphatidylinositol [3,4, 5]-trisphosphate; PDK1: phosphoinositide-dependent
    kinase 1; Raf: rapidly fibrosarcoma; Ras: rat sarcoma; Rheb: Ras homolog enriched
    in brain; TSC: tuberous sclerosis complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - IRSp53
  - IleRS
  - chico
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Tsc
  - Tsc1
  - Akt
  - Erk7
  - rl
  - Dsor1
  - Mtk
  - Rheb
  - raptor
  - Mtor
  - Tor
  - INSR
  - IGF1R
  - INSRR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTG1
  - RHEB
  - RHEBP1
  - MTOR
  - IGF1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
